Common use of Documentation and Transfer Process Clause in Contracts

Documentation and Transfer Process. In connection with the transfer of the Antibody Material as described in Section 6.1, the following shall apply: (a) Novartis will share with Company any MSDSs and customs value information to the extent (i) readily available to Novartis (and not otherwise available to Company), and (ii) reasonably necessary to permit Company to pick up the Antibody Material in accordance with Applicable Law and this Agreement; (b) Company will be solely responsible for any re-testing associated with the Antibody Material prior to use; (c) with respect to any released Antibody Material, Novartis will provide the certificate of analysis associated with its release; (d) Company will be responsible for all documentation, licenses, customs clearance, costs, etc. that are needed for and related to the pick-up, transport, and subsequent delivery of the Antibody Material to the first destination as designated by Company and thereafter; (e) unless Novartis otherwise agrees in writing, the Antibody Material will not be picked up from any one location in more than one installment; and (f) the Antibody Material made available by Novartis will only be used according to its specifications, including release specifications, and in accordance with Applicable Laws, and Novartis will have no further obligation with respect to the Antibody Material.